Two Sigma Investments, LP Virios Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.07 - $6.12 $72,348 - $108,789	-17,776 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.61 - $6.56 $52,341 - $74,482	-11,354 Reduced 38.98%	17,776 $94,000
Q2 2021 Aug 16, 2021	SELL	$4.71 - $6.95 $368,340 - $543,517	-78,204 Reduced 72.86%	29,130 $183,000
Q1 2021 May 17, 2021	BUY	$5.01 - $8.84 $537,743 - $948,832	107,334 New	107,334 $615,000

991K

Ticker VIRI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,330,400
Market Cap $3.12M
Description
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.